# Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease

> **NCT01288053** · PHASE1,PHASE2 · TERMINATED · sponsor: **Northwestern University** · enrollment: 9 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** Allogeneic Stem Cell Therapy

## Key facts

- **NCT ID:** NCT01288053
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** No participant enrolled more than two years. No plan to continue study.
- **Last updated:** 2018-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01288053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01288053, "Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01288053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*